Contract between SMTC Manufacturing Corporation and Company dated November 9, 2004 Standard SMTC Contract Rev 08.rtf CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • March 31st, 2005 • Onscreen Technologies Inc • Services-advertising
CONTRACT MANUFACTURING AGREEMENT dated as of July 2, 2023 by and between BorgWarner (Shanghai) Automobile Fuel Systems Co., Ltd. and BorgWarner Poland sp. z o.oContract Manufacturing Agreement • July 7th, 2023 • Phinia Inc. • Motor vehicle parts & accessories
ContractContract Manufacturing Agreement • April 5th, 2019 • TransMedics Group, Inc. • Electromedical & electrotherapeutic apparatus • London
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing AgreementContract Manufacturing Agreement • April 27th, 2021
(OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that it has signed a multi-year contract manufacturing agreement (“CMA”) for the filling and packaging of vaporizer devices, subject to approval by Health Canada, for Cronos Group Inc.’s (NASDAQ:CRON) (TSX:CRON) (“Cronos Group”) adult-use brand, COVE™.
Contract Manufacturing Agreement, Principle To Principle And Loan License Agreements Under Drug LawsContract Manufacturing Agreement • December 30th, 2021
Historically pharmaceutical companies turned to contract manufacturers for achieving efficiencies in cost, capacity and time-to-market, or to obtain specific expertise not available in-house. However, the increment in outsourcing of manufacture is driven, at least in part, by the fact that contract manufacturers have increasingly developed innovative proprietary processes and implemented technology that may well surpass that available at the pharmaceutical client's own facilities. Moreover, nowadays few pharmaceuticals are made in dedicated plants and key intermediates and active compounds can be made in general-purpose plants.
Contract Manufacturing AgreementContract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • April 6th, 2022 • Embecta Corp. • Surgical & medical instruments & apparatus • Delaware
This Contract Manufacturing Agreement (this “Agreement”) is made and entered into as of March 31, 2022, with effectiveness as of 12:01 a.m., New York City time, on April 1, 2022 (the “Effective Date”) by and between Becton, Dickinson and Company, a New Jersey corporation (“BD”), and Embecta Corp., a Delaware corporation (“SpinCo”). Parent and SpinCo are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ContractContract Manufacturing Agreement • February 6th, 2023 • New South Wales
Contract Manufacturer has agreed to supply, and Customer has agreed to purchase, the Products in exchange for the Invoiced Amount. The parties agree that, by reference to this document, the terms contained in this document and any terms contained in a Contract Manufacturing Agreement (if applicable), govern the purchase and supply of Products (collectively, the “Agreement”).
AMENDMENT NO. 5 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 5 (the “Amendment”) is made as of October 13 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, Inc. with offices at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin Pharmaceuticals, LLC”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
EX-10.5 4 g10422exv10w5.htm EX-10.5 CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • May 5th, 2020 • New York
THIS CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made this 1st.day of November, 2005 (the “Agreement Date”), by and between JDS Pharmaceuticals, LLC. (“JDS”), a Delaware Limited Liability Company with a principal place of business at 122 East 42nd. Street New York, NY 10168 USA, and OSG NORWICH PHARMACEUTICALS, INC (“NPI”), a Delaware corporation with a principal place of business at 6826 State Highway 12, Norwich, NY 13815 USA. Recitals A. JDS is engaged in the business of, among other things, marketing and distributing certain pharmaceutical products. B. NPI is in the business of contract manufacturing and packaging pharmaceutical products, and providing related services. C. JDS has agreed to purchase from NPI, and NPI has agreed to provide to JDS, certain manufacturing and quality assurance services relating to certain of JDS’s products, on the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other go
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • March 1st, 2019 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
This Contract Manufacturing Agreement is made by and between (1) Fresenius Kabi Austria GmbH, having its registered office at Hafnerstrasse 36, A-8055 Graz, Austria (“FRESENIUS”) and (2) AMAG Pharmaceuticals, Inc., a Delaware corporation having an office at 1100 Winter Street, Waltham, MA 02451, U.S.A. (“COMPANY”), effective as of September 1, 2018 (the “Effective Date”).
First Amendment to Contract Manufacturing Agreement (Metreleptin SLD) dated September 30, 2010Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT (“Amendment”) entered into as of September 01, 2011 is by and between Amylin Pharmaceuticals, Inc., whose principal office is at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin”) and Sandoz GmbH, whose principal office is at Biochemiestrasse 10, A6250 Kundl, Austria (“Sandoz”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 8th, 2008 • Prestige Brands Holdings, Inc. • Pharmaceutical preparations • Groningen
Medtech Products Inc., a company organized and existing under the laws of the State of Delaware, USA, having its principal place of business at 90 North Broadway, Irvington, New York 10533, together with any affiliate thereof, hereinafter called “Medtech”;
CONTRACT MANUFACTURING AGREEMENT TO INITIATE LOCAL PRODUCTION OF AN ESSENTIAL MEDICINE TO TREAT A CHRONIC DISEASEContract Manufacturing Agreement • September 6th, 2023
Aspen is pleased to confirm that it has concluded a fourth contract manufacturing agreement towards its strategic plan to fill its recently expanded sterile manufacturing capacity. One of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Ltd, has concluded an agreement with a multinational pharmaceutical group for the technical transfer and commercial manufacture of an essential medicine to treat a chronic disease.
THIRD AMENDED CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • March 8th, 2024 • Honest Company, Inc. • Retail-catalog & mail-order houses • California
This Third Amended Contract Manufacturing Agreement (the "Agreement") is entered into as of January 1, 2024 (the "Effective Date"), by and between The Honest Company, Inc., a Delaware corporation, having a principal place of business at 12130 Millennium Drive, Suite 500, Los Angeles, California 90094 ("Honest"), and Valor Brands LLC, a.k.a. Ontex, a limited liability company organized and existing under the laws of the State of Delaware, having a principal place of business at 5900 Windward Pkwy # 100, Alpharetta, GA 30005 ("Supplier"). Honest and Supplier shall hereinafter be individually referred to as a "Party" and, collectively, as the "Parties."
EX-10.17 15 dex1017.htm CONTRACT MANUFACTURING GENERAL AGREEMENT BETWEEN THE REGISTRANT AND MEDTECH CONTRACT MANUFACTURING GENERAL AGREEMENTContract Manufacturing Agreement • May 5th, 2020 • New Jersey
This Contract Manufacturing General Agreement (the “Agreement”) is entered into as of this 13th day of February 2008 (the “Effective Date”), by and between TissueLink Medical, Inc., a Delaware corporation, having its principal place of business at 1 Washington Center, Suite 400, Dover, NH 03820 (the “Customer”), and The MedTech Group, Inc., a New Jersey corporation, having its principal place of business at 6 Century Road, South Plainfield, NJ 07080 (the “Manufacturer”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • January 28th, 2019 • Pioneer Power Solutions, Inc. • Power, distribution & specialty transformers • California
This CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made as of January 22, 2019, by and between Cleanspark, Inc., a Nevada corporation (“Cleanspark”) and Pioneer Power Solutions, Inc., a Delaware corporation (“Pioneer”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 23rd, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • Washington
This CONTRACT MANUFACTURING AGREEMENT (the "Agreement") is entered into as of October 16, 2000 (the "Effective Date"), by and between ICOS Corporation ("ICOS"), a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 22021 20th Avenue SE, Bothell, WA 98021 USA and Seattle Genetics, Inc. ("SGI"), a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 22215 26th Avenue S.E., Suite 3000, Bothell, WA 98021.
Certain portions of this Exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K and, where applicable, have been marked with “[***]” to indicate where redactions have been made. CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • September 30th, 2022 • LiveWire Group, Inc. • Motorcycles, bicycles & parts • Delaware
This CONTRACT MANUFACTURING AGREEMENT (this “Agreement”) is made as of September 26, 2022 (the “Effective Date”), by and between Harley-Davidson Motor Company Group, LLC, a limited liability company formed in Wisconsin, United States of America (“HD”), and LiveWire EV, LLC, a Delaware limited liability company (“LiveWire”). HD and LiveWire are each a “Party” and are sometimes referred to herein collectively as the “Parties.”
CONTRACT MANUFACTURER FOR PRIVATE LABEL AND INDIVIDUAL PRODUCTSContract Manufacturing Agreement • September 26th, 2023
are some of the main characteristics that have distinguished NUTRILO, under the roof of the PHW Group, as a partner of national and international customers for almost 40 years.
RECITALSContract Manufacturing Agreement • March 28th, 2003 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
EX-10.2 3 d457076dex102.htm EX-10.2 NOTE: PORTIONS OF THIS EXHIBIT INDICATED BY [****] ARE SUBJECT TO A CONFIDENTIAL TREATMENT REQUEST, AND HAVE BEEN OMITTED FROM THIS EXHIBIT. COMPLETE, UNREDACTED COPIES OF THIS EXHIBIT HAVE BEEN FILED WITH THE...Contract Manufacturing Agreement • May 5th, 2020 • Delaware
This Contract Manufacturing Agreement, dated as of August 3, 2017 (the “CMA”), is entered into by and between RTI Surgical, Inc., a Delaware corporation (“Seller”), and A&E Advanced Closure Systems, LLC, a Delaware limited liability company (“Buyer”, and together with Seller, the “Parties”, and each, a “Party”).
GES") - 1 - 2 CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • August 10th, 2001 • Global Election Systems Inc • Services-computer integrated systems design • Ohio
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • June 27th, 2014 • Zep Inc. • Specialty cleaning, polishing and sanitation preparations • Georgia
This CONTRACT MANUFACTURING AGREEMENT (“Agreement”) is entered into as of May 30, 2014 (“Effective Date”) by Amrep, Inc., a company organized under the laws of the State of Delaware with its principal place of business at c/o Zep Inc., 1310 Seaboard Industrial Blvd., Atlanta, GA 30318 and doing business as “Zep Commercial Sales & Service” (“Zep”), and Apollo Technologies, Inc., a company organized under the laws of the State of Georgia with its principal place of business at 1850 South Cobb Industrial Blvd., Smyrna, GA 30082 (“Apollo”) (Zep and Apollo are referred to collectively as the “Parties”). As used in this document the term “Agreement” shall include all exhibits attached hereto and all supply orders issued hereunder.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE SONO GROUP N. V. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) IS THE TYPE THAT SONO GROUP N. V. TREATS AS PRIVATE OR CONFIDENTIAL....Contract Manufacturing Agreement • April 19th, 2022 • Sono Group N.V. • Motor vehicles & passenger car bodies
This Binding Term Sheet (the “Term Sheet”) is entered into by and between Sono Motors GmbH (“Sono Motors”), with a business address of Waldmeisterstraße 76, 80935 Munich, the Federal Republic of Germany and Valmet Automotive Inc. (“Valmet Automotive”), with a business address of Autotehtaankatu 14, 23500 Uusikaupunki, Finland, as of the date last signed below (the “Effective Date”). Each of Sono Motors and Valmet Automotive will be referred to individually herein as a “Party” and collectively as “the Parties.”
AMENDMENT NO. 4 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 4 (the “Amendment”) is made as of 23rd June 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with a principal place of business at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
AMENDMENT TO CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • January 20th, 2005 • Dyadic International Inc • Services-commercial physical & biological research
AMENDMENT NO. 3 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 3 (the “Amendment”) is made as of 8th July 2013 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with offices at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
AMENDMENT NO. 4 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 4 (the “Amendment”) is made as of 23rd June 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with a principal place of business at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • June 20th, 2006 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This CONTRACT MANUFACTURING AGREEMENT (this “Agreement”) is made and entered into this 5th day of March, 2003 (the “Effective Date”), by and between BOSTON SCIENTIFIC CORPORATION (“BSC”) a Delaware corporation, and OSIRIS ACQUISITION II, INC. (“Osiris”), a Delaware corporation (each a “Party,” and collectively, the “Parties”).
CONTRACT MANUFACTURING AGREEMENT AMONG ONYX PHARMACEUTICALS, INC., ONYX PHARMACEUTICALS INTERNATIONAL GMBH AND CAMBRIDGE MAJOR LABORATORIES, INC. CONFIDENTIALContract Manufacturing Agreement • February 28th, 2013 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Contract Manufacturing Agreement (the “Agreement”) is entered into as of the 25th day of June, 2012 (“Effective Date”) by and among CAMBRIDGE MAJOR LABORATORIES, INC., a Wisconsin corporation, having its principal address at W130 N10497 Washington Drive, Germantown, Wisconsin 53022 (“CAMBRIDGE”), ONYX PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business at 249 East Grand Avenue, South San Francisco, Califomia 94080 and ONYX PHARMACEUTICALS INTERNATIONAL GMBH, a Swiss limited liability corporation, having its principal place of business at Dammstrasse 19, 6300 Zug, Switzerland (collectively, herein referred to as “ONYX”). CAMBRIDGE and ONYX may each be referred to herein as a “Party” and collectively, the “Parties.”
Contract Manufacturing AgreementContract Manufacturing Agreement • May 10th, 2012 • Medicines Co /De • Pharmaceutical preparations • Delaware
WHEREAS, MDCO wishes to have the Product manufactured, packaged, tested, and supplied to it by APP for commercial sales, and APP wishes to manufacture, package, test and supply to MDCO the Product for commercial sales, in accordance with the terms and conditions of this Agreement; and
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • November 7th, 2007 • Fabrinet • New York
THIS CONTRACT MANUFACTURING AGREEMENT is made effective as of November 15, 2004 (Effective Date) between JDS Uniphase Corporation, having offices at 1768 Automation Parkway, San Jose, California, 95131, on behalf of itself and its affiliates and subsidiaries (collectively, JDSU) and Fabrinet having offices at 294 Moo 8, Vibhavadi Rangsit Road Kookot, Lamlooka Pathumthani, Thailand 12130, on behalf of itself and its affiliates and subsidiaries (collectively, Supplier).
CONTRACT MANUFACTURING AGREEMENT By and Among STR Solar (Hong Kong), Limited ZheJiang FeiYu Photo-Electrical Science & Technology Co., Ltd. and Zhejiang Xiesheng Group Co., Ltd.Contract Manufacturing Agreement • May 7th, 2014 • STR Holdings, Inc. • Unsupported plastics film & sheet
THIS CONTRACT MANUFACTURING AGREEMENT, made as of 13 JAN, 2014, by and between STR Solar (Hong Kong), Limited, a company organized and existing under the laws of Hong Kong Special Administrative Region (hereinafter called “Hong Kong”) of the People’s Republic of China (hereinafter called “China”), and having its office and place of business at Room D, 32nd Floor, Lippo Centre, Tower 1, 89 Queensway, Hong Kong(hereinafter called “STR”), ZheJiang FeiYu Photo-Electrical Science & Technology Co., Ltd., a company organized and existing under the laws of China, and having its office and place of business at No. 6 Xinghang 1 Road Industry Functional Zone, Hangbu Town, Ke Cheng District, Quzhou City, Zhejiang Province, China_(“FeiYu”), and Zhejiang Xiesheng Group Co., Ltd., a company organized and existing under the laws of China, and having its office and place of business at No. 119, West Zijing Road, Quzhou City, Zhejiang Province, China (“Xiesheng”; .together with FeiYu hereinafter called
Contract Manufacturing AgreementContract Manufacturing Agreement • April 4th, 2022 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations • New York
Customer Galderma, or following any termination of this Agreement by Galderma pursuant to clause 16 (Termination), Sol-Gel or its designated Affiliate or licensee, in accordance with clause 16.5 (Effect of Termination as to Galderma).
